Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4.40M | $101.0M | 9.71% | +295.0K | 2026-03-31 |
| INFINITUM ASSET MANAGEMENT, LLC | 4.15M | $95.0M | 9.16% | +25.0K | 2026-03-31 |
| HHLR ADVISORS, LTD. | 3.93M | $90.0M | 8.67% | -- | 2026-03-31 |
| ORBIMED ADVISORS LLC | 3.03M | $69.0M | 6.68% | -- | 2026-03-31 |
| FMR LLC | 3.02M | $69.0M | 6.66% | -687.4K | 2026-03-31 |
| BlackRock, Inc. | 2.53M | $58.0M | 5.58% | +157.5K | 2026-03-31 |
| Octagon Capital Advisors LP | 1.97M | $45.0M | 4.35% | -- | 2026-03-31 |
| NOVO HOLDINGS A/S | 1.94M | $44.0M | 4.29% | -- | 2026-03-31 |
| Sofinnova Investments, Inc. | 1.70M | $39.0M | 3.74% | -- | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.53M | $35.0M | 3.37% | -- | 2026-03-31 |
